For the Inventor, By the Inventor

Enter assignee name

Amgen Canada Inc.

USPTO Granted Patents = 14

% Expired Patents = 14.3

EPO Patents = 1

Forward Citations = 172

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Tak Wah Mak (5 out of 32 patents)

Toshifumi Matsuyama (3 out of 3 patents)

Alex Grossman (3 out of 3 patents)

4. Jane McGlade (2 out of 3 patents)

5. Lea Anne Harrington (2 out of 5 patents)

6. Murray O Robinson (2 out of 16 patents)

7. Ursula Kapp (2 out of 2 patents)

8. Rosemary Schmandt (2 out of 2 patents)

9. Christopher Donald Richardson (2 out of 2 patents)

10. Josef Martin Penninger (2 out of 5 patents)

11. Kurt Bachmaier (2 out of 2 patents)

12. Andrew John Hessel (2 out of 2 patents)

13. Nickolaus Neu (2 out of 2 patents)

14. Arda Shahinian (1 out of 2 patents)

15. Anna Tafuri Bladt (1 out of 2 patents)

14 patents: Sort by Forward Citations

1. 8309083 - Polypeptides involved in immune response (2012-11-13),

2. 7312024 - Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth (2007-12-25),

3. 6492138 - Polynucleotides encoding a novel SHC-binding protein (2002-12-10),

4. 6468528 - Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth (2002-10-22),

5. 6399747 - Shc-binding protein (2002-06-04),

6. 6369202 - Genes encoding LSIRF polypeptides (2002-04-09),

7. 6258935 - LSIRF polypeptides (2001-07-10),

8. 6034230 - Nucleic acids encoding myocardial peptides (2000-03-07),

9. 5981707 - Genes encoding telomerase protein 1 (1999-11-09),

10. 5962636 - Peptides capable of modulating inflammatory heart disease (1999-10-05),

11. 5919656 - Genes encoding telomerase protein 1 (1999-07-06),

12. 5907079 - MSH2 disrupted mice develop lymphomas (1999-05-25),

13. 5891666 - Genes encoding LSIRF polypeptides (1999-04-06),

14. 5714667 - Mice lacking expression of CTLA-4 receptor (1998-02-03),

Amgen Canada Inc. is a biotechnology company focused on the development and manufacturing of innovative therapies for serious illnesses. The organization specializes in areas such as oncology, nephrology, and inflammation, leveraging advanced biopharmaceutical technologies to create effective treatments. With a commitment to scientific excellence, Amgen Canada plays a vital role in the healthcare landscape, contributing to the improvement of patient outcomes through its research and development initiatives.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#66 in

#1,066 in Canada

#42,199 in the World

Amgen Canada Inc.

Forward Citations = 172

19 inventors:

Tak Wah Mak (5 out of 32 patents)

Toshifumi Matsuyama (3 out of 3 patents)

Alex Grossman (3 out of 3 patents)

4. Jane McGlade (2 out of 3 patents)

5. Lea Anne Harrington (2 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…